Posts by Michael Phelan
What is Going on with DePuy ASR Hip Replacement Litigation?
I’ve been reading reports by various bloggers, Bloomberg News, and the National Law Journal that Johnson & Johnson, DePuy Orthopaedic’s parent company, is considering whether to agree to pay $3 billion to settle more than 10,000 cases filed concering its defective metal-on-metal ASR hip replacement device. The implication is that the MDL plaintiffs’ steering committee and/or other plaintiff lawyers who […]
Read MoreIs a Kickback the Reason Your Pharmacist or Physician Recommended That New Drug?
Two federal lawsuits charge Novartis Pharmaceuticals with making fraudulent kickbacks to promote sales of its drug, Myofortic.
Less than three years ago, Novartis settled criminal and civil investigations into whether it had illegally promoted …
Read MoreMeet Nancy Hull Davidson
Phelan Petty is excited to announce the hiring of attorney, Nancy H. Hull. Prior to joining the firm, Nancy worked in Washington, D.C. at a well-respected international law firm, White & Case, where she practiced in the fields of investment and commercial arbitration. Nancy will practice primarily in our securities and white collar criminal defense…
Read MoreFirm resolves case for $3.25 million for brain injured child
In a case scheduled to go to trial on January 7, 2013, our firm and our co-counsel, Leila Kilgore, successfully resolved a case for a five year old chld who suffered a traumatic brain injury at four months of age. The defendants in the case contended that the child had no residual effects from the…
Read MoreHas Dr. Drew Been Pimping Wellbutrin to his Listeners for GlaxoSmithKline?
This is a story about how the pharmaceutical industry pollutes the safety and efficacy regulatory process by the use of kickbacks and aggressive consumer marketing, including celebrity spokespersons. The story is getting more play because it has …
Read More